Allen Carr 'Easyway': Difference between revisions

Jump to navigation Jump to search
no edit summary
(→‎About the book: visual edit)
No edit summary
Line 9: Line 9:
==Its success rate==  
==Its success rate==  


It should be noted that an RCT exists, [[https://journals.sagepub.com/doi/full/10.1177/014556131709600701|Randomized, Controlled Trial Using Best-Selling Smoking-Cessation Book]] that did not find that 'Easyway' was particularly, if at all effective
It should be noted that an RCT exists [[ https://journals.sagepub.com/doi/full/10.1177/014556131709600701|Prospective, Randomized, Controlled Trial Using Best-Selling Smoking-Cessation Book]] that did not find that 'Easyway' was particularly, if at all effective


A  RCT exists that is altogether more [https://tobaccocontrol.bmj.com/content/tobaccocontrol/28/4/414.full.pdf positive] though it should be noted the study was funded by ACE (Allen Cars Easyway) as is mentioned here https://www.eurekalert.org/pub_releases/2020-01/sfts-nss011620.php therefore aproached with caution. Indeed any vaping study that is funded by a vaping company is often fobbed off as 'propaganda', and dismissed no matter how solid the findings!
A  RCT exists that is altogether more [https://tobaccocontrol.bmj.com/content/tobaccocontrol/28/4/414.full.pdf positive] though it should be noted the study was funded by ACE (Allen Cars Easyway) as is mentioned here https://www.eurekalert.org/pub_releases/2020-01/sfts-nss011620.php therefore approached with caution. Indeed any vaping study that is funded by a vaping company is often fobbed off as 'propaganda', and dismissed no matter how solid the findings!


Another very recent 2020 entry [https://onlinelibrary.wiley.com/doi/10.1111/add.14897 Comparison of Allen Carr's Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial] is neutral in its conclusions 'There was no clear evidence of a difference in the efficacies of the Allen Carr's Easyway (ACE) and specialist smoking cessation support involving behavioural support and pharmacotherapy'.
Another very recent 2020 entry [https://onlinelibrary.wiley.com/doi/10.1111/add.14897 Comparison of Allen Carr's Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial] is neutral in its conclusions 'There was no clear evidence of a difference in the efficacies of the Allen Carr's Easyway (ACE) and specialist smoking cessation support involving behavioural support and pharmacotherapy'.
Line 21: Line 21:
From an email we received 28th Dec, again from Dr [[Jonathan Foulds]]:
From an email we received 28th Dec, again from Dr [[Jonathan Foulds]]:


:"The bottom line is that anyone who claims they have a 80% or higher success rate in helping typical smokers to abstain long-term is kidding themselves or trying to fool you. Same goes for anyone claiming >50%, particularly if there is no pharmacological component to the intervention. This includes varenicline, e-cigs or anything else we currently have. Generally speaking, a 1 year quit rate above 10% is not bad, 20% is very good, and 25% is awesome."
:"The bottom line is that anyone who claims they have an 80% or higher success rate in helping typical smokers to abstain long-term is kidding themselves or trying to fool you. Same goes for anyone claiming >50%, particularly if there is no pharmacological component to the intervention. This includes varenicline, e-cigs or anything else we currently have. Generally speaking, a 1-year quit rate above 10% is not bad, 20% is very good, and 25% is awesome."


His brief evaluation is here  
His brief evaluation is here  
Administrators, administrator, Bureaucrats, Interface administrators, Suppressors, Administrators, translator
211

edits

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Navigation menu